<DOC>
	<DOCNO>NCT00617994</DOCNO>
	<brief_summary>This open label study INCB018424 topical cream apply 2 - 20 % BSA patient active , stable plaque psoriasis .</brief_summary>
	<brief_title>Open Label , Safety Efficacy Study Topical Investigational Drug Treat Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects must psoriatic lesion measure protocol specific BSA Lesions solely involve palm hand , sol foot , intertriginious area , scalp face Pustular psoriasis erythroderma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>psoriasis</keyword>
</DOC>